Benzinga's M&A Chatter for Thursday July 18, 2013

Loading...
Loading...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday July 18, 2013:
Gentex to Acquire HomeLink for $700MThe Deal
:

Gentex
GNTX
announced Thursday the signing of a definitive agreement to acquire HomeLink from Johnson Controls
JCI
for $700M. Under the terms of the agreement, Gentex will acquire all of Johnson Controls' HomeLink assets, intellectual property, testing facilities, and the talented employees who manage and support the business, for a purchase price of $700 million. The deal is expected to close on or about September 30, 2013. Gentex closed at $23.71 Thursday, a gain of 3% on 1.5 times average volume.
Yelp to Acquire SeatMe for $12.7M in Cash an Stock DealThe Deal
:

Yelp
YELP
announced Thursday it has agreed to acquire SeatMe, a web-based reservation solution for restaurants and nightlife. Under the terms of the deal agreement, Yelp will acquire SeatMe for approximately $2.2 million in cash and up to approximately 263,000 shares of its Class A common stock, for a total purchase price of approximately $12.7 million. The transaction is expected to close on or about July 24, 2013. Yelp closed at $39.75 Thursday and traded at $40.29 after-hours.
Dell Special Meeting of Stockholders Adjourned, Vote on Michael Dell $13.65/Share Offer Postponed Until July 24The Adjournment
:
Loading...
Loading...

Dell
DELL
announced that Thursday's Special Meeting of Stockholders was convened and adjourned to provide additional time to solicit proxies from Dell stockholders. No vote was taken Thursday on Michael Dell's $13.65 per share proposal. The Special Meeting will reconvene on July 24, 2013 at 5 PM CDT. Dell closed at $13.12 Thursday, a loss of $0.24 on almost twice average volume.
Reuters Reports Pfizer Won't Bid for OnyxThe Rumor
:

Shares of Onyx Pharmaceuticals
ONXX
sold off sharply late Thursday on a report from
Reuters
that Pfizer
PFE
has decided not to pursue a bid for Onyx. Pfizer was one of several drug companies expected to submit bids for Onyx. Amgen's
AMGN
$120 per share offer was rejected on June 30. A spokesperson for Pfizer was not available for comment. Onyx Pharmaceuticals closed at $128.55 Thursday, a loss of more than 3% on almost 4 times average volume.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsRumorsM&AMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...